ドラッグデリバリーシステムの世界市場レポート 2025年

ドラッグデリバリーシステムの市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.3%で586億4,000万米ドルに成長します。この予測期間における成長の背景には、個別化医療の重視の高まり、複雑で高感度な医薬品のパイプラインの増加、希少疾患や希少疾病の有病率の上昇、革新的な送達技術に対する支持的な規制の枠組み、高齢者人口の拡大などがあります。この期間に予想される主な動向としては、ナノテクノロジーに基づくドラッグデリバリーシステムの進展、放出制御および徐放性メカニズムの革新、特殊なデリバリー方法を必要とする生物製剤およびバイオシミラーの進歩、スマートドラッグデリバリーデバイスの統合、腫瘍学に特化した標的デリバリーソリューションの開発などが挙げられます。

呼吸器疾患の有病率の上昇は、今後数年間のドラッグデリバリーシステム市場の成長を牽引すると予想されます。呼吸器疾患は、肺や気道の正常な機能を乱し、呼吸困難や酸素摂取量の減少を引き起こす疾患です。このような疾患の増加は、大気汚染の深刻化が主な原因であり、人々は有害な空気中の粒子やガスにさらされ、肺機能を損傷し、呼吸器疾患の発症や進行の一因となります。ドラッグデリバリーシステムは、喘息、慢性閉塞性肺疾患（COPD）、肺線維症、嚢胞性線維症などの呼吸器疾患の効果的な治療と管理に重要な役割を果たしています。これらのシステムは、薬剤を肺に直接送達することを可能にし、全身的な副作用を軽減しながら治療効果を向上させる。例えば、2025年3月、英国の政府機関である英国健康安全保障局は、2024年にイングランドにおける結核症例が13％増加し、2023年の4,850症例から5,480症例に増加すると報告しました。その結果、呼吸器疾患の有病率の増加がドラッグデリバリーシステム市場を促進すると予想されます。

ドラッグデリバリーシステム市場の主な企業は、ユーザーの快適性と使いやすさを向上させるために、メタルフリーの多用量鼻腔スプレーポンプのような先進的なソリューションの開発に注力しています。これらのメタルフリー多剤式点鼻ポンプは、金属部品を組み込むことなく、鼻腔ルートから複数回分の薬剤を投与するように設計されており、安全性と様々な製剤との適合性を確保しています。例えば、2023年1月、米国に本社を置く製薬会社Aptar Pharma社は、APF Futurityメタルフリー多剤式点鼻ポンプを発表しました。この装置は、生理食塩水や同様の市販品を点鼻するために特別に設計されたもので、リサイクル可能であることに重点を置いています。Aptar Pharma初のリサイクル性の高い点鼻薬ポンプであり、欧州のリサイクル基準であるcyclos-HTPのクラスAA認証を取得しています。ポリオレフィン材料のみで構成され、金属部品やリサイクル汚染物質を含まないため、リサイクルが容易になり、リサイクル材料の品質が向上します。Aptar PharmaのAdvanced Preservative Freeテクノロジーを採用したこの金属フリーのポンプは、正確で一貫した投与とスムーズな操作を提供し、使いやすさと有効性を維持します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のドラッグデリバリーシステム：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のドラッグデリバリーシステム市場：成長率分析
• 世界のドラッグデリバリーシステム市場の実績：規模と成長、2019年～2024年
• 世界のドラッグデリバリーシステム市場の予測：規模と成長、2024年～2029年、2034年
• 世界のドラッグデリバリーシステム：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界のドラッグデリバリーシステム市場：タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 注射ベースドラッグデリバリーシステム
• 経口ドラッグデリバリーシステム
• 吸入または肺ドラッグデリバリーシステム
• 経粘膜ドラッグデリバリーシステム
• 世界のドラッグデリバリーシステム市場：材料別、実績と予測、2019年～2024年、2024年～2029年、2034年
• ポリマーベースのドラッグデリバリーシステム
• 脂質ベースのドラッグデリバリーシステム
• 無機的なドラッグデリバリーシステム
• 生物学的ベースのドラッグデリバリーシステム
• ハイブリッドドラッグデリバリーシステム
• 世界のドラッグデリバリーシステム市場：用途別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 感染症
• 腫瘍学
• 眼科
• 泌尿器科
• 糖尿病
• 中枢神経系
• その他の用途
• 世界のドラッグデリバリーシステム市場：エンドユーザー別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 病院
• 製薬会社
• 研究機関
• 在宅ケア設定
• 診断検査室
• 世界のドラッグデリバリーシステム市場、注射ベースドラッグデリバリーシステムのタイプ別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 静脈内（IV）
• 筋肉内（IM）
• 皮下（SC）
• 皮内
• 脊髄内
• デポ注射
• 無針注射器
• 世界のドラッグデリバリーシステム市場、経口ドラッグデリバリーシステムのタイプ別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• タブレット
• カプセル
• 溶液とシロップ
• サスペンション
• 粉末と顆粒
• 放出制御製剤
• 世界のドラッグデリバリーシステム市場、吸入または肺ドラッグデリバリーシステムのタイプ別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 定量噴霧式吸入器（MDI）
• ドライパウダー吸入器（DPI）
• ネブライザー
• ソフトミスト吸入器
• 鼻スプレー
• 世界のドラッグデリバリーシステム市場、経粘膜ドラッグデリバリーシステムのタイプ別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 口腔内投与
• 舌下投与
• 直腸送達
• 膣投与
• 鼻粘膜送達

第7章 地域別・国別分析

• 世界のドラッグデリバリーシステム市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 世界のドラッグデリバリーシステム市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ドラッグデリバリーシステム市場：競合情勢
• ドラッグデリバリーシステム市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bayer AG
• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Abbott Laboratories Inc.
• Novartis AG
• GlaxoSmithKline PLC
• Eli Lilly and Company
• Amgen Inc.
• Becton, Dickinson and Company
• Teva Pharmaceutical Industries Ltd.
• Boston Scientific Corporation
• Tandem Diabetes
• Pacira Biosciences
• Poseida Therapeutics

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ドラッグデリバリーシステム市場2029年：新たな機会を提供する国
• ドラッグデリバリーシステム市場2029年：新たな機会を提供するセグメント
• ドラッグデリバリーシステム市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Drug delivery systems are innovative technologies or methods developed to transport therapeutic agents within the body in a controlled and efficient way. These systems are designed to improve treatment effectiveness and safety by controlling the rate, timing, and location of drug release. They help maintain optimal drug concentrations at target sites, minimize side effects, and enhance patient adherence to prescribed treatments.

The primary categories of drug delivery systems include injection-based drug delivery systems, oral drug delivery systems, inhalation or pulmonary drug delivery systems, and transmucosal drug delivery systems. Injection-based drug delivery systems are medical devices used to administer drugs into the body via various injection routes, utilizing tools such as syringes, needles, or auto-injectors for precise and targeted delivery. These systems can be made from different material types, including polymer-based, lipid-based, inorganic, biologics-based, and hybrid drug delivery systems. They are used to treat conditions such as infectious diseases, cancer, eye disorders, urinary diseases, diabetes, central nervous system disorders, and more. Key end-users of these systems include hospitals, pharmaceutical companies, research institutions, homecare providers, and diagnostic laboratories.

The drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides drug delivery systems market statistics, including drug delivery systems industry global market size, regional shares, competitors with a drug delivery systems market share, detailed drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the drug delivery systems industry. This drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug delivery system market size has grown strongly in recent years. It will grow from $41.17 billion in 2024 to $44.21 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth during the historic period can be attributed to increasing investments in research and development, a surge in chronic disease prevalence, the expansion of biologics and monoclonal antibodies, rising demand for non-invasive drug delivery methods, and the growing need to enhance patient compliance and adherence.

The drug delivery system market size is expected to see strong growth in the next few years. It will grow to $58.64 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The projected growth in the forecast period can be attributed to an increased emphasis on personalized medicine, a growing pipeline of complex and sensitive pharmaceuticals, a rising prevalence of rare and orphan diseases, supportive regulatory frameworks for innovative delivery technologies, and an expanding geriatric population. Key trends expected during this period include the advancement of nanotechnology-based drug delivery systems, innovations in controlled-release and sustained-release mechanisms, progress in biologics and biosimilars that require specialized delivery methods, the integration of smart drug delivery devices, and the development of targeted delivery solutions specifically for oncology.

The rising prevalence of respiratory disorders is expected to drive the growth of the drug delivery systems market in the coming years. Respiratory disorders are conditions that disrupt the normal function of the lungs and airways, causing breathing difficulties and reduced oxygen intake. The increase in these disorders is largely due to escalating air pollution, which exposes people to harmful airborne particles and gases that damage lung function and contribute to the onset and progression of respiratory diseases. Drug delivery systems play a vital role in the effective treatment and management of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and cystic fibrosis. These systems enable medications to be delivered directly to the lungs, improving therapeutic effectiveness while reducing systemic side effects. For example, in March 2025, the UK Health Security Agency-a government body in the UK-reported that tuberculosis cases in England rose by 13% in 2024, increasing from 4,850 cases in 2023 to 5,480 cases. Consequently, the growing prevalence of respiratory disorders is expected to propel the drug delivery systems market.

Key players in the drug delivery systems market are concentrating on developing advanced solutions like metal-free, multidose nasal spray pumps to enhance user comfort and ease of use. These metal-free, multidose nasal spray pumps are designed to administer multiple medication doses through the nasal route without incorporating any metal parts, ensuring safety and compatibility with various formulations. For example, in January 2023, Aptar Pharma, a pharmaceutical company based in the U.S., introduced the APF Futurity metal-free, multidose nasal spray pump. This device is specifically engineered for delivering nasal saline and similar over-the-counter products, with a strong emphasis on recyclability. It is Aptar Pharma's first highly recyclable nasal spray pump, earning a Class AA certification from cyclos-HTP for European recycling standards. Constructed entirely from polyolefin materials and free from metal components or recycling contaminants, it facilitates easier recycling and enhances the quality of recycled materials. Incorporating Aptar Pharma's Advanced Preservative Free technology, this metal-free pump provides precise and consistent dosing with smooth operation, maintaining ease of use and effectiveness.

In January 2024, Kindeva Drug Delivery, a U.S.-based contract development and manufacturing organization, acquired Summit Biosciences Inc. for an undisclosed sum. This acquisition expanded Kindeva's drug delivery capabilities by adding a new platform. It enables the company to provide biopharmaceutical clients with a broader portfolio of advanced drug-device combination products, including those for pulmonary, injectable, transdermal, and nasal delivery. Summit Biosciences Inc. is a U.S.-based contract development and manufacturing firm specializing in intranasal drug delivery.

Major players in the drug delivery systems market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories Inc., Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Tandem Diabetes, Pacira Biosciences, Poseida Therapeutics, Universal Stabilization Technologies Inc., Spectrum Pharmaceuticals Inc., VasoRx Inc.

North America was the largest region in the drug delivery system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in drug delivery systems report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug delivery systems market consists of sales of implantable devices, targeted delivery carriers, nanoparticle-based systems, and bio adhesive systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Injection-Based Drug Delivery System; Oral Drug Delivery System; Inhalation Or Pulmonary Drug Delivery System; Transmucosal Drug Delivery System
• 2) By Material: Polymer-Based Drug Delivery Systems; Lipid-Based Drug Delivery Systems; Inorganic Drug Delivery Systems; Biologics-Based Drug Delivery Systems; Hybrid Drug Delivery Systems
• 3) By Application: Infectious Disease; Oncology; Ophthalmology; Urology; Diabetes; Central Nervous System; Other Applications
• 4) By End-User: Hospitals; Pharmaceutical Companies; Research Institutions; Homecare Settings; Diagnostic Laboratories
• Subsegments:
• 1) By Injection-Based Drug Delivery System: Intravenous (IV); Intramuscular (IM); Subcutaneous (SC); Intradermal; Intrathecal; Depot Injections; Needle-Free Injectors
• 2) By Oral Drug Delivery System: Tablets; Capsules; Solutions And Syrups; Suspensions; Powders And Granules; Modified Release Formulations
• 3) By Inhalation Or Pulmonary Drug Delivery System: Metered Dose Inhalers (MDIs); Dry Powder Inhalers (DPIs); Nebulizers; Soft Mist Inhalers; Nasal Sprays
• 4) By Transmucosal Drug Delivery System: Buccal Delivery; Sublingual Delivery; Rectal Delivery; Vaginal Delivery; Nasal Mucosal Delivery
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Delivery Systems Market Characteristics

3. Drug Delivery Systems Market Trends And Strategies

4. Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Drug Delivery Systems Growth Analysis And Strategic Analysis Framework

• 5.1. Global Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Drug Delivery Systems Market Growth Rate Analysis
• 5.4. Global Drug Delivery Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Drug Delivery Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Drug Delivery Systems Total Addressable Market (TAM)

6. Drug Delivery Systems Market Segmentation

• 6.1. Global Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injection-Based Drug Delivery System
• Oral Drug Delivery System
• Inhalation Or Pulmonary Drug Delivery System
• Transmucosal Drug Delivery System
• 6.2. Global Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymer-Based Drug Delivery Systems
• Lipid-Based Drug Delivery Systems
• Inorganic Drug Delivery Systems
• Biologics-Based Drug Delivery Systems
• Hybrid Drug Delivery Systems
• 6.3. Global Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Disease
• Oncology
• Ophthalmology
• Urology
• Diabetes
• Central Nervous System
• Other Applications
• 6.4. Global Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Pharmaceutical Companies
• Research Institutions
• Homecare Settings
• Diagnostic Laboratories
• 6.5. Global Drug Delivery Systems Market, Sub-Segmentation Of Injection-Based Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous (IV)
• Intramuscular (IM)
• Subcutaneous (SC)
• Intradermal
• Intrathecal
• Depot Injections
• Needle-Free Injectors
• 6.6. Global Drug Delivery Systems Market, Sub-Segmentation Of Oral Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Solutions And Syrups
• Suspensions
• Powders And Granules
• Modified Release Formulations
• 6.7. Global Drug Delivery Systems Market, Sub-Segmentation Of Inhalation or Pulmonary Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metered Dose Inhalers (MDIs)
• Dry Powder Inhalers (DPIs)
• Nebulizers
• Soft Mist Inhalers
• Nasal Sprays
• 6.8. Global Drug Delivery Systems Market, Sub-Segmentation Of Transmucosal Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Buccal Delivery
• Sublingual Delivery
• Rectal Delivery
• Vaginal Delivery
• Nasal Mucosal Delivery

7. Drug Delivery Systems Market Regional And Country Analysis

• 7.1. Global Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Delivery Systems Market

• 8.1. Asia-Pacific Drug Delivery Systems Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Delivery Systems Market

• 9.1. China Drug Delivery Systems Market Overview
• 9.2. China Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Delivery Systems Market

• 10.1. India Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Delivery Systems Market

• 11.1. Japan Drug Delivery Systems Market Overview
• 11.2. Japan Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Delivery Systems Market

• 12.1. Australia Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Delivery Systems Market

• 13.1. Indonesia Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Delivery Systems Market

• 14.1. South Korea Drug Delivery Systems Market Overview
• 14.2. South Korea Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Delivery Systems Market

• 15.1. Western Europe Drug Delivery Systems Market Overview
• 15.2. Western Europe Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Delivery Systems Market

• 16.1. UK Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Delivery Systems Market

• 17.1. Germany Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Delivery Systems Market

• 18.1. France Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Delivery Systems Market

• 19.1. Italy Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Delivery Systems Market

• 20.1. Spain Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Delivery Systems Market

• 21.1. Eastern Europe Drug Delivery Systems Market Overview
• 21.2. Eastern Europe Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Delivery Systems Market

• 22.1. Russia Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Delivery Systems Market

• 23.1. North America Drug Delivery Systems Market Overview
• 23.2. North America Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Delivery Systems Market

• 24.1. USA Drug Delivery Systems Market Overview
• 24.2. USA Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Delivery Systems Market

• 25.1. Canada Drug Delivery Systems Market Overview
• 25.2. Canada Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Delivery Systems Market

• 26.1. South America Drug Delivery Systems Market Overview
• 26.2. South America Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Delivery Systems Market

• 27.1. Brazil Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Delivery Systems Market

• 28.1. Middle East Drug Delivery Systems Market Overview
• 28.2. Middle East Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Delivery Systems Market

• 29.1. Africa Drug Delivery Systems Market Overview
• 29.2. Africa Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Delivery Systems Market Competitive Landscape And Company Profiles

• 30.1. Drug Delivery Systems Market Competitive Landscape
• 30.2. Drug Delivery Systems Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Drug Delivery Systems Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi S.A.
• 31.3. Bristol-Myers Squibb Company
• 31.4. AstraZeneca PLC
• 31.5. Abbott Laboratories Inc.
• 31.6. Novartis AG
• 31.7. GlaxoSmithKline PLC
• 31.8. Eli Lilly and Company
• 31.9. Amgen Inc.
• 31.10. Becton, Dickinson and Company
• 31.11. Teva Pharmaceutical Industries Ltd.
• 31.12. Boston Scientific Corporation
• 31.13. Tandem Diabetes
• 31.14. Pacira Biosciences
• 31.15. Poseida Therapeutics

32. Global Drug Delivery Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Delivery Systems Market

34. Recent Developments In The Drug Delivery Systems Market

35. Drug Delivery Systems Market High Potential Countries, Segments and Strategies

• 35.1 Drug Delivery Systems Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Drug Delivery Systems Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Drug Delivery Systems Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer